You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: September 29, 2023

Paragraph IV Challenges

✉ Email this page to a colleague

« Back to Dashboard

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Tradename	Dosage	Generic Name	NDA	ANDAs Submitted	180 Day Exclusivity Status	Submissiondate
KLOXXADO	Nasal Spray	naloxone hydrochloride	212045	1		2023-03-30
SPRAVATO	Nasal Spray	esketamine hydrochloride	211243	3		2023-03-06
SUTAB	Tablets	magnesium sulfate; potassium chloride; sodium sulfate	213135	1		2023-03-03
PHEXXI	Vaginal Gel	citric acid; lactic acid; potassium bitartrate	208352	1		2023-02-28
>Tradename	>Dosage	>Generic Name	>NDA	>ANDAs Submitted	>180 Day Exclusivity Status	>Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.